2023-11-13T16:41:37-05:00 2022-12-31 274760605 KULLMAN CPA LLC 888 BESTGATE ROAD SUITE 316 ANNAPOLIS MD 21401 990EZ 2022-01-01 882591503 THE N 1 COLLABORATIVE INC N1CO 7 CAROLE PLACE SOMERVILLE MA 02143 WINSTON YAN PRESIDENT 2023-11-10 WINSTON YAN 999009999 true STEPHEN J KULLMAN CPA P00308157 4102669885 2023-11-10 2022 2023-04-26 12:10:37Z X X WWW.N1COLLABORATIVE.ORG X X 92600 X 92600 92600 24604 40239 33568 98411 -5811 -5811 X 26463 0 26463 32274 0 -5811 X OUR MISSION IS TO MAKE INDIVIDUALIZED MEDICINES ROUTINELY AND RAPIDLY ACCESSIBLE TO RARE DISEASE PATIENTS WORLDWIDE. TO SUPPORT SCIENTIFIC RESEARCH AND THE DEVELOPMENT OF INDIVIDUALIZED MEDICINES FOR PATIENTS WITH RARE DISEASE. SPECIFIC EXAMPLE: BEGAN PILOT DATABASES TO AGGREGATE AND DISSEMINATE PRECLINICAL AND CLINICAL DATA. SCOPED FUTURE DATA 16690 TO EDUCATE THE GLOBAL COMMUNITY ABOUT INDIVIDUALIZED MEDICINES. ACCOMPLISHMENT: EXPANDED WORKGROUPS (PATIENT IDENTIFICATION, PRECLINICAL DESIGN, DATA COORDINATION, CLINICAL OUTCOME MEASURES, AND INSTITUTIONAL IMPLEMENTATION), AND ESTABLISHED GOALS, OVERALL PRIORITIES, AND KEY MILESTONES. HOSTED COLLABORATIVE MEETINGS AND WORKSHOPS TO BEGIN WORKSTREAMS. SPECIFIC EXAMPLE: CREATED SIGNIFICANT COMMUNITY MOMENTUM FOR STANDARDS AND DESIGN SERVER; WILLINGNESS EXPRESSED BY MANY TO COLLABORATE ON THIS. 16688 TO EDUCATE THE GLOBAL COMMUNITY ABOUT INDIVIDUALIZED MEDICINES. SPECIFIC EXAMPLE: HELD CONFERENCES AND SEMINARS OPEN TO ALL STAKEHOLDERS TO ADVANCE IMPORTANT CONVERSATIONS. 3711 37089 WINSTON YAN PRESIDENT 5.00 0 JULIA VITARELLO SECRETARY 5.00 0 TIM YU TREASURER 5.00 0 ANNEMIEKE AARTSMA-RUS BOARD MEMBER 2.00 0 KEITH FLANAGAM BOARD MEMBER 2.00 0 HOLM GRAESSNER BOARD MEMBER 0.50 0 NICOLE BOICE BOARD MEMBER 0.50 0 false false false false false false false false false EVA ZHECHEVA 48 KENT RD LYNN MA 01904 9785488949 false false false false false false false false false false false NONE NONE true X 92600 92600 92600 92600 90748 1852 92600 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 EXPENSES ADVERTISING & MARKETING 750 BRANDING 6,955 PAYROLL PROCESSING EXPENSE 111 HUMAN RESOURCE FEES 43 OFFICE SUPPLIES 1,705 BANK FEES & CHARGES 1 SOFTWARE LICENSES 327 AIRFARE 2,113 AIRFARE 2,113 AIRFARE 470 LODGING 5,485 LODGING 5,485 LODGING 1,219 GROUND TRANSPORTATION & PARKI 429 GROUND TRANSPORTATION & PARKI 429 GROUND TRANSPORTATION & PARKI 95 TRAVEL MEALS 1,461 TRAVEL MEALS 1,461 TRAVEL MEALS 325 TRAVEL - OTHER 497 TRAVEL - OTHER 497 TRAVEL - OTHER 111 WORKERS' COMPENSATION INSURAN 50 DUES & SUBSCRIPTIONS 1,436 TOTAL 33,568 FORM 990-EZ, PART II, LINE 26 ACCOUNTS PAYABLE AND ACCRUED EXPENSES 0 32,274 FORM 990-EZ, PART III OUR MISSION IS TO MAKE INDIVIDUALIZED MEDICINES ROUTINELY AND RAPIDLY ACCESSIBLE TO RARE DISEASE PATIENTS WORLDWIDE. FORM 990-EZ, PART III, LINE 28 TO SUPPORT SCIENTIFIC RESEARCH AND THE DEVELOPMENT OF INDIVIDUALIZED MEDICINES FOR PATIENTS WITH RARE DISEASE. SPECIFIC EXAMPLE: BEGAN PILOT DATABASES TO AGGREGATE AND DISSEMINATE PRECLINICAL AND CLINICAL DATA. SCOPED FUTURE DATA FORM 990-EZ, PART III, LINE 29 TO EDUCATE THE GLOBAL COMMUNITY ABOUT INDIVIDUALIZED MEDICINES. ACCOMPLISHMENT: EXPANDED WORKGROUPS (PATIENT IDENTIFICATION, PRECLINICAL DESIGN, DATA COORDINATION, CLINICAL OUTCOME MEASURES, AND INSTITUTIONAL IMPLEMENTATION), AND ESTABLISHED GOALS, OVERALL PRIORITIES, AND KEY MILESTONES. HOSTED COLLABORATIVE MEETINGS AND WORKSHOPS TO BEGIN WORKSTREAMS. SPECIFIC EXAMPLE: CREATED SIGNIFICANT COMMUNITY MOMENTUM FOR STANDARDS AND DESIGN SERVER; WILLINGNESS EXPRESSED BY MANY TO COLLABORATE ON THIS.